Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine
- PMID: 6827552
- DOI: 10.1021/jm00357a002
Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine
Abstract
A dihydropyridine in equilibrium pyridinium salt type redox system is described as a general and flexible method for site-specific and sustained delivery of drugs to the brain. According to this, a biologically active compound linked to a lipoidal dihydropyridine carrier easily penetrates the blood-brain barrier. Oxidation of the carrier part in vivo to the ionic pyridinium salt prevents its elimination from the brain, while elimination from the general circulation is accelerated. Subsequent cleavage of the quaternary carrier-drug species results in sustained delivery of the drug in the brain and facile elimination of the carrier part. The concept is illustrated with phenethylamine as the drug and trigonelline as the quaternary carrier. One injection to rats of 1-methyl-3-(N-phenethylcarbamoyl)-1,4-dihydropyridine resulted in continuous build up in the brain of the corresponding 1-methyl-3-(N-phenethylcarbamoyl)pyridinium salt, reaching a maximum at about 80 min. At this time, the general circulation was practically void of either compound, while the accumulated carrier-drug species provided a source for sustained drug delivery only in the brain.
Similar articles
-
Site-specific, sustained release of drugs to the brain.Science. 1981 Dec 18;214(4527):1370-2. doi: 10.1126/science.7313698. Science. 1981. PMID: 7313698
-
Improved delivery through biological membranes XIV: Brain-specific, sustained delivery of testosterone using a redox chemical delivery system.J Pharm Sci. 1984 Mar;73(3):385-9. doi: 10.1002/jps.2600730324. J Pharm Sci. 1984. PMID: 6716249
-
Improved delivery through biological membranes. 13. Brain-specific delivery of dopamine with a dihydropyridine in equilibrium with pyridinium salt type redox delivery system.J Med Chem. 1983 Apr;26(4):528-34. doi: 10.1021/jm00358a013. J Med Chem. 1983. PMID: 6834384
-
Targeting drugs to the brain by redox chemical delivery systems.Med Res Rev. 2000 Sep;20(5):367-416. doi: 10.1002/1098-1128(200009)20:5<367::aid-med3>3.0.co;2-p. Med Res Rev. 2000. PMID: 10934349 Review.
-
Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.Curr Drug Metab. 2017;18(2):129-137. doi: 10.2174/1389200218666170113125132. Curr Drug Metab. 2017. PMID: 28088890 Review.
Cited by
-
Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine.Pharm Res. 2013 Oct;30(10):2523-37. doi: 10.1007/s11095-012-0966-3. Pharm Res. 2013. PMID: 24137801
-
Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIP.J Med Chem. 2022 Aug 25;65(16):11111-11125. doi: 10.1021/acs.jmedchem.2c00562. Epub 2022 Aug 5. J Med Chem. 2022. PMID: 35930706 Free PMC article.
-
Improved delivery through biological membranes. XXXVII. Synthesis and stability of novel redox derivatives of naproxen and indomethacin.Pharm Res. 1989 Aug;6(8):667-76. doi: 10.1023/a:1015930220855. Pharm Res. 1989. PMID: 2813259
-
Anxiolytic activity of a brain delivery system for GABA.Psychopharmacology (Berl). 1987;92(2):157-63. doi: 10.1007/BF00177908. Psychopharmacology (Berl). 1987. PMID: 2885884
-
Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists.J Pharm Sci. 1994 Jan;83(1):46-53. doi: 10.1002/jps.2600830112. J Pharm Sci. 1994. PMID: 8138909 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources